Genmab — December 2018
-
Jeg er ret overbevist om at det eneste der skal til er en accellerering af væksten i omsætning. Det øger multiplerne (PE) investorer kan leve med og vil kan nemt føre til store stigninger. Accellereringen kan blive tydeligt ret hurtigt med godkendelse i første linje. Det er også derfor jeg kigger nøje på hvor hurtigt de får den godkendelse ...
-
-
Christina Gasparetto, MD of the Duke Cancer Institute talks about
Selinexor, Daratumumab and Dexamethasone for Relapsed/Refractory Myeloma https://www.youtube.com/watch?v=oDyWR6T4ZCU -
Dr. Natalie Callander, MD of the University of Wisconsin talks about the DETER study, which looked into a combination of Daratumumab, Revlimid and Dexamethasone for treating high-risk smoldering myeloma. https://www.youtube.com/watch?v=FaaOjJmCODI
-
Dr. Shahzad Raza, MD of Saint Luke's Cancer Institute talks about a trial investigating the treatment of newly diagnosed multiple myeloma with a four drug combination of Daratumumab, Revlimid, Dexamethasone and Velcade. SC. https://www.youtube.com/watch?v=vCdZQnyCxOk
-
Dr. Mike Thompson, MD, PhD of Aurora Health Care talks about a trial investigating Daratumumab, Velcade, Dexamethasone with or without Venetoclax https://www.youtube.com/watch?v=gqFnHwkGtMY ("adding venetoclax to the backbone of standard of care")
-
-
Dara er priseffektiv i RRMM https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25372
-
peter12. Ikke kun pris effiktiv men også langt færre bivirkninger: " Overall tolerability is
worse in patients on pomalidomide, who experience higher rates of central nervous system
effects, diarrhea, cramping, rashes, and a more significant impact on blood counts." -
New DARA-study, phase 4!, in Indian participants https://clinicaltrials.gov/ct2/show/NCT03768960?term=Daratumumab+OR+Ofatumumab+OR+Tisotumab&lupd_s=12%2F01%2F2018&lupd_e=12%2F10%2F2018&rank=1
-
-
Rafael Fonseca, MD, Five medical ways to optimize the value of care. Good for patients, payers and good medicine. 1. Right treatment, 2. Durable initial remissions re likely best-value, 3. Avoid unnecessary exposure to toxicity….https://twitter.com/Rfonsi1/status/1071865959470616576
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind